Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar SnowBawl (< 20) Submitted: 2/24/2011 9:55:43 AM : Outperform Start Price: $35.83 REGN Score: +182.66

target

Featured Broker Partners


Advertisement